Loading…

Studies on the synthesis and characterization of four trans-planaramineplatinum(II) complexes of the form trans-PtL(NH3)CL2 where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-α)pyridine

Four trans-planaramineplatinum(II) complexes code named YH9, YH10, YH11 and YH12, each of the form trans-PtL(NH3)Cl2 where L = 2-hydroxypyridine and 3-hydroxypyridine, imidazole, and imidazo(1,2-α)pyridine for YH9, YH10, YH11 and YH12, respectively. All of the compounds have significant anticancer a...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2004-08, Vol.39 (8), p.691-697
Main Authors: Huq, Fazlul, Daghriri, Hassan, Yu, Jun Qing, Beale, Philip, Fisher, Keith
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Four trans-planaramineplatinum(II) complexes code named YH9, YH10, YH11 and YH12, each of the form trans-PtL(NH3)Cl2 where L = 2-hydroxypyridine and 3-hydroxypyridine, imidazole, and imidazo(1,2-α)pyridine for YH9, YH10, YH11 and YH12, respectively. All of the compounds have significant anticancer activity against human cancer cell lines. YH12 is found to be significantly more active than cisplatin against cisplatin-resistant ovary cell line A2780cisR.
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2004.04.005